- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1411EUR$1,600USD£1,239GBP
€1763EUR$2,000USD£1,549GBP
- Report
- September 2025
- 250 Pages
Global
From €3958EUR$4,490USD£3,477GBP
- Report
- December 2025
- 150 Pages
Global
From €3394EUR$3,850USD£2,981GBP
- Report
- October 2025
- 150 Pages
Global
From €3394EUR$3,850USD£2,981GBP
- Report
- August 2025
- 150 Pages
Global
From €2513EUR$2,850USD£2,207GBP
€3394EUR$3,850USD£2,981GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2459EUR$2,789USD£2,160GBP
- Report
- September 2025
- 110 Pages
Global
From €3500EUR$4,253USD£3,182GBP
- Report
- October 2025
- 160 Pages
Global
From €2960EUR$3,358USD£2,600GBP
€3482EUR$3,950USD£3,059GBP
- Report
- August 2025
- 199 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- September 2025
- 250 Pages
Global
From €3958EUR$4,490USD£3,477GBP
- Report
- December 2025
- 278 Pages
Global
From €5157EUR$5,850USD£4,530GBP
- Report
- October 2025
- 250 Pages
Global
From €3958EUR$4,490USD£3,477GBP
- Report
- February 2025
- 135 Pages
Global
From €15865EUR$17,995USD£13,934GBP
- Report
- January 2024
- 150 Pages
Global
From €5246EUR$5,950USD£4,607GBP
- Report
- April 2024
- 115 Pages
Global
From €3967EUR$4,500USD£3,485GBP
- Report
- August 2022
- 120 Pages
Global
From €3967EUR$4,500USD£3,485GBP
- Report
- March 2024
- 200 Pages
Global
From €3659EUR$4,150USD£3,213GBP
- Report
- December 2024
- 152 Pages
Global
From €2786EUR$3,160USD£2,447GBP
€3482EUR$3,950USD£3,059GBP
- Report
- December 2024
- 30 Pages
Global
From €1940EUR$2,200USD£1,704GBP
€2424EUR$2,750USD£2,129GBP
- Report
- December 2024
- 30 Pages
Global
From €1940EUR$2,200USD£1,704GBP
€2424EUR$2,750USD£2,129GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more